ANDERSON KERRII B sold $954K of LH
ANDERSON KERRII B sold 3,000 shares of LABCORP HOLDINGS INC. (LH) at $318.02 ($0.95M total) on 2026-08-17 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
This is a disclosed open-market sale of 3,000 shares at a stated price, executed under a pre-arranged Rule 10b5-1 plan, which generally limits the inference traders draw about near-term fundamentals.
Market read
Traders may note the insider sale for sentiment/positioning, but the 10b5-1 structure makes it less actionable as a fundamental catalyst.
What to watch
The article provides no information on whether other insiders sold, whether the director’s total stake is changing materially over time, or any concurrent company-specific catalysts.
Background
The article is an SEC Form 4 insider transaction disclosure for Labcorp Holdings Inc. (LH) by director Anderson Kerrii B.
Ticker impact
SEC Form 4 shows director Anderson Kerrii B sold 3,000 shares of LH on 2026-08-17 at $318.02/share under a 10b5-1 plan.
Low likelihood of a sustained price move solely from this disclosure; any impact is likely short-lived.
The filing is an open-market sale by a director executed under a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary sales.
Market effects
No clear sector read-through from a single director 10b5-1 sale.
None indicated.
None indicated.
Counterpoint
Even with a 10b5-1 plan, repeated insider selling can coincide with internal expectations of weaker near-term performance, so traders may still fade rallies around the disclosure window.
Key entities
- issuerLABCORP HOLDINGS INC.
Subject of the Form 4 insider transaction disclosure (ticker LH).
- insiderANDERSON KERRII B
Director who sold 3,000 shares of LH under a 10b5-1 plan.
